JPMorgan keeps an Overweight rating and $80 price target on Viking Therapeutics (VKTX) after the company announced that it has initiated the ...

The Pittsburgh Steelers could very well be looking for a Donte Jackson replacement in free agency in 2025 and one NFL analyst ...

In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $42.53, marking a -0.84% move from the previous day.

Minnesota is also weak on the defensive line. The Vikes got gashed by Jahmyr Gibbs and the Detroit Lions for 139 yards and ...

Kansas City has been looking for ways to bolster the offensive line and Bleacher Report's Kristopher Knox floated Minnesota ...

The New York Giants will be in the market for their next franchise quarterback this offseason. While they’re widely expected ...

In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $40.25, indicating a +1.19% shift from the previous trading day.

NFL season is nearing the finish line as the playoffs draw near. And already the 2025 quarterback market is beginning to take ...

Viking Therapeutics Inc’s profitability metrics reveal strong financial health. The company currently boasts a gross margin of -16.62%. The profit margin, also known as the revenue ratio or gross ...

Having examined the options trading patterns of Viking Therapeutics, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance ...

The Minnesota Vikings dodged the mess that former starting quarterback Kirk Cousins is now navigating with the Atlanta Falco.